JIM MURPHY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2010-11-12 Jim Murphy(6) 347,500 *
2011-02-18 Jim Murphy(5)
2012-11-19 Jim Murphy(5) — * Mr. Murphy's employment with the company ended March 31, 2012.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22